Managing cutaneous vasculitis in a patient with lupus erythematosus.
Lesions and rashes are the most common dermatologic manifestation in patients who have lupus erythematosus and are directly related to inflammation of the small and medium-size vessels of the skin. Inflammation of these vessels is known as cutaneous vasculitis and is often an indicator that a more severe, life-threatening inflammatory process could be occurring in the major organs of the body.
Pullen
Richard L
RL
Amarillo College, Division of Nursing, Amarillo, TX, USA.
D000893:Anti-Inflammatory Agents / Q000627:therapeutic use; D001706:Biopsy; D003937:Diagnosis, Differential; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use; D008180:Lupus Erythematosus, Systemic / Q000150:complications* / Q000175:diagnosis / Q000628:therapy; D008297:Male; D008875:Middle Aged; D009730:Nursing Assessment; D010787:Photosensitivity Disorders / Q000209:etiology / Q000517:prevention & control; D012867:Skin / Q000098:blood supply*; D014657:Vasculitis / Q000175:diagnosis / Q000209:etiology / Q000628:therapy
D000893:Anti-Inflammatory Agents; D007166:Immunosuppressive Agents